首页> 美国卫生研究院文献>EFSA Journal >Assessment of the application for renewal of authorisation of AveMix®XG 10 (endo‐14‐beta‐xylanase and endo‐13(4)‐beta‐glucanase) for chickens for fattening
【2h】

Assessment of the application for renewal of authorisation of AveMix®XG 10 (endo‐14‐beta‐xylanase and endo‐13(4)‐beta‐glucanase) for chickens for fattening

机译:评估AVEMIX®授权续期申请用于鸡的XG 10(Endo-14-β-木聚糖酶和Endo-13(4)-β-葡聚糖酶用于育肥

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed ( ) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of AveMix 10 (endo‐1,4‐beta‐xylanase and endo‐1,3(4)‐beta‐glucanase) for chickens for fattening. The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation. There is no new evidence that would lead the Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for the target species, consumer and the environment under the authorised conditions of use. Regarding user safety, the additive is not considered to be a dermal or eye irritant but it is a dermal and respiratory sensitiser. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.
机译:遵循欧盟委员会的请求后,动物饲料()中使用的添加剂和产品或物质小组被要求提供科学意见,就评估股票授权申请 10(Endo-1,4-β-木聚糖酶和肠胃1,3(4)-β-葡聚糖酶)用于鸡以进行肥育。申请人提供了证据表明,目前市场上的添加剂符合现有的授权条件。没有新的证据,将导致小组重新考虑其前一个结论。因此,小组得出结论,添加剂在授权使用条件下对目标物种,消费者和环境仍然是安全的。关于用户安全性,添加剂不被认为是皮肤或眼睛刺激物,但它是一种皮肤和呼吸敏感剂。无需评估添加剂在授权的更新范围内的疗效。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号